Product Number : |
|
Product Name : |
Ranibizumab |
CAS No. : |
347396-82-1 |
Synonyms : |
Ranibizumab |
Chemical Name : |
|
Molecular Formula : |
|
Molecular Weight : |
|
Molecular Structure : |
|
Appearance : |
|
Specification : |
|
Application : |
|
Registration : |
|
Storage Condition : |
Ranibizumab is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment designed for intraocular use. Ranibizumab binds to and inhibits the biologic activity of human vascular endothelial growth factor A (VEGF-A). Ranibizumab, which lacks an Fc region, has a molecular weight of approximately 48 kilodaltons and is produced by CHO expression system.
Statement:
->>Products covered by valid patents are not offered or supplied for commercial use.
->>Products currently covered by valid US Patents are offered for laboratory R&D use in accordance with 35 USC 271(e)+A13(1).
->>Any patent infringement and resulting liability is solely at buyer's risk.
->>Our products are only raw materials for drugs or industry, can't be used for human or animals directly.